Opioid properties of beta-lipotropin fragment 60-65, H-Arg-Try-Gly-Gly-Phe-Met-OH.
D000698:Analgesia; D000818:Animals; D006168:Guinea Pigs; D007082:Ileum; D066298:In Vitro Techniques; D008297:Male; D008345:Manganese / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology; D009842:Oligopeptides / Q000378:metabolism / Q000494:pharmacology*; D011957:Receptors, Opioid / Q000378:metabolism*; D012964:Sodium / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013574:Synaptosomes / Q000378:metabolism; D014649:Vas Deferens; D008083:beta-Lipotropin / Q000378:metabolism / Q000494:pharmacology*
D009842:Oligopeptides; D011957:Receptors, Opioid; D009270:Naloxone; D008345:Manganese; D009020:Morphine; D008083:beta-Lipotropin; D012964:Sodium